Literature DB >> 24162272

Appropriateness of laboratory testing in inflammatory bowel disease inpatients: an opportunity to reduce unnecessary healthcare costs.

Aoibhlinn O'Toole1, Gavin C Harewood.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24162272     DOI： 10.1007/s10620-013-2910-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  The rise in health care spending and what to do about it.

Authors:  Kenneth E Thorpe
Journal:  Health Aff (Millwood)       Date:  2005 Nov-Dec       Impact factor: 6.301

2.  The rising prevalence of treated disease: effects on private health insurance spending.

Authors:  Kenneth E Thorpe; Curtis S Florence; David H Howard; Peter Joski
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Jun       Impact factor: 6.301

Review 3.  Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.

Authors:  K T Park; Dorsey Bass
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

4.  Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.

Authors:  A Bassi; S Dodd; P Williamson; K Bodger
Journal:  Gut       Date:  2004-10       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.